Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nucana Plc ADR (NQ: NCNA )

1.270 -0.010 (-0.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Nucana Plc ADR

< Previous 1 2 3 4 5 6 Next >
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
Via Benzinga
Topics Stocks
Exposures US Equities
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1... 
Via Benzinga
NCNA Stock Earnings: NuCana Beats EPS for Q2 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
NCNA Stock Earnings: NuCana Beats EPS for Q1 2024
NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
NCNA Stock Earnings: NuCana Misses EPS for Q4 2023
NCNA stock results show that NuCana missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data
NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival... 
Via Benzinga
NuCana: Q4 Earnings Insights
Via Benzinga
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
Why NuCana (NCNA) Shares Are Trading Lower
NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs). 
Via Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Dow Surges Over 100 Points; Dollar Tree Earnings Miss Expectations
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.28% to 39,113.63 while the NASDAQ fell 0.25% to 16,225.31. The S&P 500... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why NuCana Stock Is Up Today
NuCana shares are trading higher Wednesday after the company was granted a U.S. Patent for phosphoramidate derivatives for use in the treatment of cancer. U.S. Patent #11925658 was granted on Tuesday... 
Via Benzinga
Topics Derivatives Intellectual Property
Exposures Derivatives Intellectual Property
Crude Oil Gains Over 2%; Gaxos.ai Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 150 points on Wednesday. The Dow traded up 0.42% to 39,170.63 while the NASDAQ fell 0.50% to 16,183.77. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24... 
Via Benzinga
US Stocks Mixed; Williams-Sonoma Earnings Top Views
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 39,037.74 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback